Advancing Innovation in Alternative Pain and Addiction Therapies Act
This bill requires the Food and Drug Administration to issue guidance clarifying eligibility and criteria for the accelerated approval of non-opioid or nonaddictive drugs to treat pain or substance-use disorders.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.